Medtronic, Inc.
FDA 510(k) & PMA Approved Devices — 141 products
Total Devices141
Categories58
Latest FDA decision2026-08-28
| Type | Number | Device Name | Code | Date | Actions |
|---|---|---|---|---|---|
| PMA | P930039 | Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes | NVN | 2026-06-24 | View |
| PMA | P140017 | Pulmonary valve prosthesis percutaneously delivered | NPV | 2026-06-09 | View |
| PMA | P200046 | Pulmonary valve prosthesis percutaneously delivered | NPV | 2026-06-01 | View |
| PMA | P140010 | Drug-Eluting Peripheral Transluminal Angioplasty Catheter | ONU | 2026-05-28 | View |
| PMA | P240036 | Permanent defibrillator electrodes | NVY | 2026-04-24 | View |
| 510(k) | K260195 | Elongated One-Piece Arterial (EOPA) 3D™ Arterial Cannulae | DWF | 2026-04-23 | View |
| PMA | P950024 | Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes | NVN | 2026-04-15 | View |
| PMA | P120017 | permanent pacemaker Electrode | DTB | 2026-04-15 | View |
| PMA | P980050 | Implantable cardioverter defibrillator (non-CRT) | LWS | 2026-04-15 | View |
| PMA | P990064 | replacement Heart-valve | DYE | 2026-03-03 | View |
| 510(k) | K253203 | Retrograde Coronary Sinus Perfusion Cannulae | DWF | 2026-02-19 | View |
| PMA | P980043 | replacement Heart-valve | DYE | 2026-02-12 | View |
| PMA | P970031 | heart-valve, non-allograft tissue | LWR | 2026-02-12 | View |
| PMA | P060039 | Drug eluting permanent left ventricular (lv) pacemaker electrode | OJX | 2026-02-10 | View |
| 510(k) | K253998 | Clearview Intracoronary Shunts | DWF | 2026-01-20 | View |
| 510(k) | K251831 | Bio-Medicus Life Support Catheter and Introducer | QHW | 2026-01-15 | View |
| 510(k) | K253511 | Concerto Versa™ Detachable Coil | KRD | 2026-01-14 | View |
| 510(k) | K253409 | C320LBB Delivery System (C320LBBS45), C320LBB Delivery System (C320LBBS48), C320LBB Delivery System (C320LBBL45), C320LBB Delivery System (C320LBBL48) | DQY | 2025-12-19 | View |
| PMA | P200028 | Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation | OAE | 2025-10-10 | View |
| 510(k) | K251258 | MC2™ Two-Stage Venous Cannula; MC2X™ Three-Stage Venous Cannula | DWF | 2025-06-20 | View |
No matching devices.
Page 2 of 8
Related Clinical Trials
NCT00271180Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRECRUITINGNCT07005232Lead Evaluation for Defibrillation and Reliability Post Approval StudyENROLLING_BY_INVITATIONNCT07507422Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation TherapyRECRUITINGNCT01516723Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary OcclusionsCOMPLETEDNCT01586910Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).ACTIVE_NOT_RECRUITINGNCT01675440Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve ReplacementCOMPLETEDNCT01984710Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+SACTIVE_NOT_RECRUITINGNCT02088554PERIGON Pivotal TrialACTIVE_NOT_RECRUITINGNCT02701283Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk PatientsACTIVE_NOT_RECRUITINGNCT03242642Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.RECRUITING